Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiko Okimura

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 17, 2006
[Laron type dwarfism]Yasuhiko Okimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2004
[Ghrelin receptor and its signal transduction]Yasuhiko Okimura, Kazuo Chihara
No Shinkei Geka. Neurological Surgery|November 8, 2006
[Diagnosis and therapy for pituitary tumors]Yasuhiko Okimura, Kazuo Chihara
Plos One|January 24, 2013
Lentiviral and Moloney retroviral expression of green fluorescent protein in somatotrophs in vivoMasayoshi Okada, Hiroko Matsuda, Yasuhiko Okimura
Biomedical Reports|April 18, 2025
Both asparagine and proline are required to decrease <i>Sestrin2</i> mRNA levels via ATF4 reduction and regulate collagen type I alpha 1 chain production and the proliferation of quiescent RI?T hepatic stellate cellsRan Sawa, Manami Ogawa, Hana Suzuki, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 14, 2021
The involvement of Sestrin2 in the effect of IGF-I and leucine on mTROC1 activity in C2C12 and L6 myocytesRan Sawa, Ikumi Wake, Yu Yamamoto, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 16, 2003
[For more accurate diagnosis of endocrine diseases: discussion]Yoshimasa Shishiba, Takashi Ishihara, Tetsuo Nishikawa, et al.
Nutrition Research (New York, N.Y.)|December 16, 2017
Glucose-mediated inactivation of AMP-activated protein kinase reduces the levels of L-type amino acid transporter 1 mRNA in C2C12 cellsYu Yamamoto, Ran Sawa, Ikumi Wake, et al.
Endocrine Journal|February 7, 2007
Hormone replacement therapy and vascular risk disorders in adult hypopituitarismHidesuke Kaji, Keiji Iida, Yutaka Takahashi, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|April 7, 2009
Difference between Japanese and Caucasian populations in the allelic frequency of growth hormone receptor polymorphismsKeiji Iida, Yutaka Takahashi, Hidesuke Kaji, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 17, 2006
[Laron type dwarfism]Yasuhiko Okimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2004
[Ghrelin receptor and its signal transduction]Yasuhiko Okimura, Kazuo Chihara
No Shinkei Geka. Neurological Surgery|November 8, 2006
[Diagnosis and therapy for pituitary tumors]Yasuhiko Okimura, Kazuo Chihara
Plos One|January 24, 2013
Lentiviral and Moloney retroviral expression of green fluorescent protein in somatotrophs in vivoMasayoshi Okada, Hiroko Matsuda, Yasuhiko Okimura
Biomedical Reports|April 18, 2025
Both asparagine and proline are required to decrease <i>Sestrin2</i> mRNA levels via ATF4 reduction and regulate collagen type I alpha 1 chain production and the proliferation of quiescent RI?T hepatic stellate cellsRan Sawa, Manami Ogawa, Hana Suzuki, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 14, 2021
The involvement of Sestrin2 in the effect of IGF-I and leucine on mTROC1 activity in C2C12 and L6 myocytesRan Sawa, Ikumi Wake, Yu Yamamoto, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 16, 2003
[For more accurate diagnosis of endocrine diseases: discussion]Yoshimasa Shishiba, Takashi Ishihara, Tetsuo Nishikawa, et al.
Nutrition Research (New York, N.Y.)|December 16, 2017
Glucose-mediated inactivation of AMP-activated protein kinase reduces the levels of L-type amino acid transporter 1 mRNA in C2C12 cellsYu Yamamoto, Ran Sawa, Ikumi Wake, et al.
Endocrine Journal|February 7, 2007
Hormone replacement therapy and vascular risk disorders in adult hypopituitarismHidesuke Kaji, Keiji Iida, Yutaka Takahashi, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|April 7, 2009
Difference between Japanese and Caucasian populations in the allelic frequency of growth hormone receptor polymorphismsKeiji Iida, Yutaka Takahashi, Hidesuke Kaji, et al.
Pageof 6